BEAT
$68.22
Biotelemetry
$.68
1.01%
BEAT
Earnings Whisper ®
N/A
1st Quarter March 2019
Consensus:  $0.43
Revenue:  $104.62 Mil
Thursday
May 23
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BEAT reports earnings?
Beat
Meet
Miss

Where is BEAT's stock price going from here?
Up
Flat
Down
Stock chart of BEAT
Analysts
Summary of analysts' recommendations for BEAT
Score
Grade
Pivots
Resistance
$70.41
$69.70
$68.96

$68.25

Support
$67.51
$66.80
$66.06
Tweet
Growth
Description
BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. It is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. BioTelemetry, Inc., formerly known as CardioNet, Inc., is headquartered in Conshohocken, Pennsylvania.
Peers
Quest DiagnosticsLaboratory Corp. of America